Ponesimod-d7
Ponesimod-d7 (ACT-128800-d7) is the deuterium-labeled Ponesimod. Ponesimod-d7 (ACT-128800) is a potent, selective and orally active agonist of S1P1, with an IC50 of 6 nM in a radioligand binding assay. Ponesimod-d7 activates S1P1-mediated signal transduction with high potency (EC50=5.7 nM). Ponesimod-d7 can protect against lymphocyte-mediated tissue inflammation[1][2][3].
Product Specifications
Product Name Alternative
ACT-128800-d7
UNSPSC
12352005
Target
Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Others
Field of Research
Others
Purity
96.50
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1N(C2=C([2H])C([2H])=C([2H])C([2H])=C2C([2H])([2H])[2H])/C(S/C1=C\C3=CC=C(OC[C@H](O)CO)C(Cl)=C3)=N/CCC
Molecular Formula
C23H18D7ClN2O4S
Molecular Weight
468.02
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
3alpha,7alpha,12alpha-Trihydroxycoprostanic Acid
P53 (BP53-12 + DO-7), CF647 conjugate, 0.1mg/mL
